| Name | Licogliflozin |
|---|
| Description | Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor. |
|---|---|
| Related Catalog | |
| Target |
SGLT1, SGLT2[1] |
| In Vitro | Licogliflozin (LIK066) is a non-anti-fibrotic treatment agent for non-alcoholic steatohepatitis (NASH). |
| References |
| Molecular Formula | C23H28O7 |
|---|---|
| Molecular Weight | 416.46 |
| Storage condition | 2-8℃ |